Biotechnology Assets, S.A. (BME:BST)
0.2160
0.00 (0.00%)
Nov 16, 2026, 3:32 PM CET
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €16.19 million as of November 16, 2026. It is the 37,539th most valuable company in the world and the 225th biggest in Spain. Its market cap has decreased by 24.22% in one year.
Market Cap
16.19M
Enterprise Value
16.82M
Revenue
2.98M
Global Rank
Country Rank
#225 Spain
PE Ratio
n/a
ChartMarket Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 16.19M, a decrease of -78.32%. That is a compound annual growth rate of -16.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 16.19M | 13.41% |
| Dec 31, 2025 | 14.27M | -21.93% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.96B |
| Laboratorios Farmaceuticos Rovi | 3.54B |
| Almirall | 2.33B |
| Faes Farma | 1.58B |
| Laboratorio Reig Jofre | 213.40M |
| Prim, S.A. | 211.75M |
| Atrys Health | 202.67M |
| Oryzon Genomics | 192.28M |